Harold Atkins profile picture

Contact Information

Harold Atkins, MD, FRCPC
613 737-7700 70341

501 Smyth Road, Box 926
Ottawa, ON K1H 8L6

Harold Atkins

Scientist, Cancer Therapeutics Program
Ottawa Hospital Research Institute
Associate Professor, Clinical Hematology
University of Ottawa
Attending Physician, Blood and Marrow Transplant Program
The Ottawa Hospital

Research Interests

Brief Biography

Selected Publications

Berard JA;Bowman M;Atkins HL;Freedman MS;Walker LA;, (2013 Oct 23), Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation, J Neurol Sci, -> view abstract

Conrad DP;Tsang JJ;Maclean M;Diallo JS;Le BF;Lemay CG;Falls TJ;Parato K;Bell JC;Atkins H;, (2013 May 28), Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphocytic Leukemia, Clin Cancer Res, Vol.19, Issue 14, 3832-3843 -> view abstract

Atkins HL;Freedman MS;, (2013 Jan), Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned, Neurotherapeutics, Vol.10, Issue 1, 68-76 -> view abstract

Le Boeuf F.;Batenchuk C;Vaha-Koskela M;Breton S;Roy D;Lemay C;Cox J;Abdelbary H;Falls T;Waghray G;Atkins H;Stojdl D;Diallo JS;Kaern M;Bell JC;, (2013), Model-based rational design of an oncolytic virus with improved therapeutic potential, Nat Commun, Vol.4, 1974 -> view abstract

Batenchuk C;Le BF;Stubbert L;Falls T;Atkins HL;Bell JC;Conrad DP;, (2013), Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity, Blood Cancer J, Vol.3, e123 -> view abstract